Goal-directed Intraoperative Fluid Therapy in High-risk Surgery
Effect of Goal-Directed Intraoperative Fluid Therapy on Outcomes Following Laparotomy of Gynecological Malignancies and Orthopedic Surgery
1 other identifier
observational
600
0 countries
N/A
Brief Summary
This study is aim to assess the effect of goal-directed intraoperative fluid therapy on patient's postoperative incidence rates of complications, length of hospitalization and hospitalization cost. This is an observational study followed cohort study design, due to the two therapies were not randomized assigned to the two cohorts. The details are described as follow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2016
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2015
CompletedFirst Posted
Study publicly available on registry
June 12, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedMay 31, 2019
May 1, 2019
1.9 years
May 28, 2015
May 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative complications
the incidence of complications related to surgeries 30 days postoperatively. The complications include pneumonia, pulmonary embolism, cardiovascular events (myocardial infarction, heart failure), wound infection, gastrointestinal bleeding,nausea and vomitting,postoperative hemorrhage, ileus, deep venous thrombosis, cerebral infarction, cerebral embolism, cerebral hemorrhage, renal insufficiency and failure. Those complications are defined strictly to the reference published in 2009 New England Journal of Medicine (N Engl J Med. 2009 Oct 1;361:1368-75)
30 days after the surgery
Secondary Outcomes (2)
hospital length of stay
participants will be followed for the duration of hospital stay, an expected average of 10 days
hospital expenses
30 days after the surgery
Study Arms (2)
Goal-directed fluid therapy
The fluid in group Goal-directed fluid therapy will be administered based upon real-time monitoring stroke volume variation and cardiac output achieved by the Flo-Trac monitoring system.
Conventional fluid therapy
The fluid in group Conventional fluid therapy will be administered based on the principle crystalloid solution: colloid solution =2-3:1. The total volume of fluid will be adjusted in accordance with blood pressure, heart rate and urine output of each patient.
Interventions
Applying continuous hemodynamic monitoring system ( Vigileo/Flotrac) to monitor Stroke Volume Variation and Cardiac Output and further manage intra-operative fluid therapy.
Applying conventional fluid therapy according to Peking Union Medical College Hospital standard.
Eligibility Criteria
Patients underwent either laparotomy of gynecological malignancies or orthopedic surgery
You may qualify if:
- Receiving elective laparotomy of gynecological malignancies (LGM): including cytoreductive surgery of ovarian cancer, radical hysterectomy and staging surgery of endometrial cancer ;
- Major elective orthopedic surgery (OS): including spinal surgery, revision surgery of hip joints ;
- Age ≥18 years, American Society of Anesthesiologists physical status I ~IV;
- No arrhythmia;
- Receiving general anesthesia;
- Requiring monitoring of direct blood pressure due to the comorbidities of patients and the nature of surgical procedures.
You may not qualify if:
- Emergent surgery;
- Patients with aortic regurgitation;
- Patients with aortic stenosis, peripheral arterial diseases or other diseases contradicting to arterial canalizations;
- Patients with mental disorders or low intelligence quotient; patients who cannot cooperate or refuse to sign the consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huang YuGuanglead
Related Publications (6)
Cecconi M, Fasano N, Langiano N, Divella M, Costa MG, Rhodes A, Della Rocca G. Goal-directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia. Crit Care. 2011;15(3):R132. doi: 10.1186/cc10246. Epub 2011 May 30.
PMID: 21624138BACKGROUNDKuper M, Gold SJ, Callow C, Quraishi T, King S, Mulreany A, Bianchi M, Conway DH. Intraoperative fluid management guided by oesophageal Doppler monitoring. BMJ. 2011 May 24;342:d3016. doi: 10.1136/bmj.d3016.
PMID: 21610051BACKGROUNDWang P, Wang HW, Zhong TD. Effect of stroke volume variability- guided intraoperative fluid restriction on gastrointestinal functional recovery. Hepatogastroenterology. 2012 Nov-Dec;59(120):2457-60. doi: 10.5754/hge12283.
PMID: 22626878BACKGROUNDRamsingh DS, Sanghvi C, Gamboa J, Cannesson M, Applegate RL 2nd. Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial. J Clin Monit Comput. 2013 Jun;27(3):249-57. doi: 10.1007/s10877-012-9422-5. Epub 2012 Dec 22.
PMID: 23264068BACKGROUNDDonati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007 Dec;132(6):1817-24. doi: 10.1378/chest.07-0621. Epub 2007 Oct 9.
PMID: 17925428BACKGROUNDChe L, Zhang XH, Li X, Zhang YL, Xu L, Huang YG. Outcome impact of individualized fluid management during spine surgery: a before-after prospective comparison study. BMC Anesthesiol. 2020 Jul 22;20(1):181. doi: 10.1186/s12871-020-01092-w.
PMID: 32698766DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yuguang Huang, MD
Peking Union Medical College Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor,Chairman
Study Record Dates
First Submitted
May 28, 2015
First Posted
June 12, 2015
Study Start
March 1, 2016
Primary Completion
February 10, 2018
Study Completion
July 1, 2018
Last Updated
May 31, 2019
Record last verified: 2019-05